These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 12766053

  • 1. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, Myles ME, Nashed YE, Mitra AK.
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [Abstract] [Full Text] [Related]

  • 2. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
    Anand B, Nashed Y, Mitra A.
    Curr Eye Res; 2003 Jun; 26(3-4):151-63. PubMed ID: 12815543
    [Abstract] [Full Text] [Related]

  • 3. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
    Majumdar S, Nashed YE, Patel K, Jain R, Itahashi M, Neumann DM, Hill JM, Mitra AK.
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
    [Abstract] [Full Text] [Related]

  • 4. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
    Katragadda S, Gunda S, Hariharan S, Mitra AK.
    Int J Pharm; 2008 Jul 09; 359(1-2):15-24. PubMed ID: 18472234
    [Abstract] [Full Text] [Related]

  • 5. Effects of antiviral medications on herpetic epithelial keratitis in mice.
    Komoto S, Higaki S, Fukuda M, Shimomura Y.
    Jpn J Ophthalmol; 2015 May 09; 59(3):194-200. PubMed ID: 25707352
    [Abstract] [Full Text] [Related]

  • 6. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
    Anand BS, Katragadda S, Gunda S, Mitra AK.
    Mol Pharm; 2006 May 09; 3(4):431-40. PubMed ID: 16889437
    [Abstract] [Full Text] [Related]

  • 7. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG, Bartels SP, Gordon YJ.
    Invest Ophthalmol Vis Sci; 1999 Feb 09; 40(2):378-84. PubMed ID: 9950596
    [Abstract] [Full Text] [Related]

  • 8. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M, Higaki S, Shimomura Y.
    Semin Ophthalmol; 2008 Feb 09; 23(4):241-7. PubMed ID: 18584562
    [Abstract] [Full Text] [Related]

  • 9. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S, Itahashi M, Deai T, Fukuda M, Shimomura Y.
    Cornea; 2006 Dec 09; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [Abstract] [Full Text] [Related]

  • 10. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug 09; 118(8):1030-6. PubMed ID: 10922194
    [Abstract] [Full Text] [Related]

  • 11. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y.
    Nippon Ganka Gakkai Zasshi; 2008 Mar 09; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [Abstract] [Full Text] [Related]

  • 12. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
    Hughes PM, Mitra AK.
    J Ocul Pharmacol; 1993 Mar 09; 9(4):299-309. PubMed ID: 8106836
    [Abstract] [Full Text] [Related]

  • 13. Herpes simplex virus keratitis in children.
    Chong EM, Wilhelmus KR, Matoba AY, Jones DB, Coats DK, Paysse EA.
    Am J Ophthalmol; 2004 Sep 09; 138(3):474-5. PubMed ID: 15364233
    [Abstract] [Full Text] [Related]

  • 14. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
    Anand BS, Katragadda S, Nashed YE, Mitra AK.
    Curr Eye Res; 2004 Sep 09; 29(2-3):153-66. PubMed ID: 15512962
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
    Asbell PA, Epstein SP, Wallace JA, Epstein D, Stewart CC, Burger RM.
    Cornea; 1998 Sep 09; 17(5):550-7. PubMed ID: 9756451
    [Abstract] [Full Text] [Related]

  • 16. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group.
    Cornea; 2001 Mar 09; 20(2):123-8. PubMed ID: 11248812
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF, Inoue Y, Kase T, Uchihori Y, Mori Y, Ohashi Y.
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug 09; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [Abstract] [Full Text] [Related]

  • 18. The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.
    Hill JM, Stern EM, Bhattacharjee PS, Malamud D, Clement C, Rodriguez P, Lukiw WJ, Ochoa AC, Foster TP, Velasco C, McFerrin HE.
    Antiviral Res; 2013 Oct 09; 100(1):14-9. PubMed ID: 23860013
    [Abstract] [Full Text] [Related]

  • 19. Oral acyclovir suppresses recurrent epithelial and stromal herpes simplex.
    Langston DP.
    Arch Ophthalmol; 1999 Mar 09; 117(3):391-2. PubMed ID: 10088820
    [No Abstract] [Full Text] [Related]

  • 20. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
    Dhaliwal DK, Romanowski EG, Yates KA, Hu D, Mah FS, Fish DN, Gordon YJ.
    J Cataract Refract Surg; 2001 Aug 09; 27(8):1288-93. PubMed ID: 11524202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.